TEVA-PROCTOSONE
TEVA-PROCTOSONE
Discontinued
DIN Number
02226391
Drug Class
Human
Market Date
Dec 30, 1996
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02226391
AIG Number0404592002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C05AA01 HYDROCORTISONE
Product Specifications
Dosage FormSuppository
Route of AdministrationRectal
AHFS Classification84:06.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
DIBUCAINE HYDROCHLORIDEActive
Strength: 5 MG
Monograph: DIBUCAINE HYDROCHLORIDE
ESCULINActive
Strength: 10 MG
Monograph: ESCULIN
FRAMYCETIN SULFATEActive
Strength: 10 MG
Monograph: FRAMYCETIN SULFATE
HYDROCORTISONE (HYDROCORTISONE ACETATE)Active
Strength: 5 MG
Monograph: HYDROCORTISONE (HYDROCORTISONE ACETATE)